Determining the Number of Employees for Purposes of the “Small Business” Definition (Current Good Manufacturing Practices and Preventive Controls Regulations for Human and Animal Food): Guidance for Industry; Availability, 29054-29055 [2019-13223]
Download as PDF
29054
Federal Register / Vol. 84, No. 120 / Friday, June 21, 2019 / Rules and Regulations
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 117 and 507
[Docket No. FDA–2018–D–0671]
Determining the Number of Employees
for Purposes of the ‘‘Small Business’’
Definition (Current Good
Manufacturing Practices and
Preventive Controls Regulations for
Human and Animal Food): Guidance
for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notification of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance for industry describing the
Agency’s current thinking on how to
determine the number of employees for
purposes of the ‘‘small business’’
definition in the current good
manufacturing practice (CGMP), hazard
analysis, and risk-based preventive
controls for human and animal food
rules. The guidance will help industry
subject to these rules determine the
number of employees for purposes of
the ‘‘small business’’ definition.
DATES: The announcement of the
guidance is published in the Federal
Register on June 21, 2019.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
jspears on DSK30JT082PROD with RULES
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
VerDate Sep<11>2014
16:42 Jun 20, 2019
Jkt 247001
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2018–D–0671 for ‘‘Determining the
Number of Employees for Purposes of
the ‘Small Business’ Definition in Parts
117 and 507 (CGMP and Preventive
Controls Regulations for Human and
Animal Food): Guidance for Industry.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
PO 00000
Frm 00026
Fmt 4700
Sfmt 4700
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov
/fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Center for
Food Safety and Applied Nutrition,
Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740.
Send two self-addressed adhesive labels
to assist that office in processing your
request. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance.
FOR FURTHER INFORMATION CONTACT:
For questions relating to CGMP,
Hazard Analysis, and Risk-Based
Preventive Controls for Human Food:
Jenny Scott, Center for Food Safety and
Applied Nutrition (HFS–300), Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2166.
For questions relating to CGMP,
Hazard Analysis, and Risk-Based
Preventive Controls for Food for
Animals: Jeanette Murphy, Center for
Veterinary Medicine (HFV–200), Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855, 240–402–
6246.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of
a guidance for industry entitled
‘‘Determining the Number of Employees
for Purposes of the ‘Small Business’
Definition in Parts 117 and 507 (CGMP
and Preventive Controls Regulations for
Human and Animal Food): Guidance for
Industry.’’ We are issuing the guidance
consistent with our good guidance
practices regulation (21 CFR 10.115).
The guidance represents the current
thinking of FDA on this topic. It does
not establish any rights for any person
and is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations. This
guidance is not subject to Executive
Order 12866.
This guidance concerns two
regulations that we have established in
E:\FR\FM\21JNR1.SGM
21JNR1
Federal Register / Vol. 84, No. 120 / Friday, June 21, 2019 / Rules and Regulations
Title 21 of the Code of Federal
Regulations (21 CFR) as part of our
implementation of the FDA Food Safety
Modernization Act (FSMA) (Pub. L.
111–353). These two regulations are part
117 (21 CFR part 117) (September 17,
2015, 80 FR 55907) and part 507 (21
CFR part 507) (September 17, 2015, 80
FR 51670). Under parts 117 and 507,
whether a business is a ‘‘small
business’’ has two main implications.
First, certain small businesses are
exempt from the human food preventive
controls requirements and the animal
food preventive controls requirements if
they are engaged only in specified lowrisk activity/food combinations. Second,
small businesses have later compliance
dates for parts 117 and 507 than larger
businesses. This guidance provides
additional information to assist
businesses in determining their status as
a ‘‘small business.’’
In the Federal Register of March 20,
2018 (83 FR 12143), we made available
a draft guidance for industry entitled
‘‘Determining the Number of Employees
for Purposes of the ‘Small Business’
Definition in Parts 117 and 507:
Guidance for Industry’’ and gave
interested parties an opportunity to
submit comments by May 21, 2018, for
us to consider before beginning work on
the final version of the guidance. We
received no substantive comments on
the draft guidance and are issuing the
guidance with editorial changes to
improve clarity and revision of one
example to improve usefulness. The
guidance announced in this notice
finalizes the draft guidance dated March
2018.
II. Electronic Access
Persons with access to the internet
may obtain the guidance at either
https://www.fda.gov/FoodGuidances or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidance.
Dated: June 17, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–13223 Filed 6–20–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF THE TREASURY
jspears on DSK30JT082PROD with RULES
Office of Foreign Assets Control
31 CFR Part 501
Reporting, Procedures and Penalties
Regulations
Office of Foreign Assets
Control, Treasury.
AGENCY:
VerDate Sep<11>2014
16:42 Jun 20, 2019
Jkt 247001
Interim final rule with request
for comments.
ACTION:
The Department of the
Treasury’s Office of Foreign Assets
Control (OFAC) is issuing this interim
final rule to amend the Reporting,
Procedures and Penalties Regulations
(the Regulations) to provide updated
instructions and incorporate new
requirements for parties filing reports on
blocked property, unblocked property,
or rejected transactions. In addition,
OFAC is revising the licensing
procedures section of the Regulations to
include information regarding OFAC’s
electronic license application
procedures and to provide additional
instructions regarding applications for
the release of blocked funds. OFAC also
is clarifying the rules governing the
availability of information under the
Freedom of Information Act (FOIA) for
information that is submitted to OFAC
pursuant to the Regulations. Finally,
OFAC is making numerous technical
and conforming edits throughout the
Regulations.
SUMMARY:
This interim final rule is
effective June 21, 2019. Written
comments may be submitted on or
before July 22, 2019.
ADDRESSES: You may submit comments
by any of the following methods:
Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions on the website for
submitting comments. Refer to Docket
Number OFAC–2019–0003.
Fax: Attn: Request for Comments
(Amendments to OFAC’s Reporting,
Procedures and Penalties Regulations)
202–622–1759.
Mail: Attn: Request for Comments
(Amendments to OFAC’s Reporting,
Procedures and Penalties Regulations),
Office of Foreign Assets Control, U.S.
Department of the Treasury, 1500
Pennsylvania Avenue NW, Freedman’s
Bank Building, Washington, DC 20220.
Refer to Docket Number OFAC–2019–
0003.
Instructions: All submissions received
must include the agency name and the
Federal Register Doc. number that
appears at the end of this document. All
comments, including attachments and
other supporting materials, will become
part of the public record and subject to
public disclosure. Sensitive personal
information, such as account numbers
or Social Security numbers, should not
be included. Comments generally will
not be edited to remove any identifying
or contact information.
FOR FURTHER INFORMATION CONTACT:
OFAC: Assistant Director for Licensing,
tel.: 202–622–2480, Assistant Director
DATES:
PO 00000
Frm 00027
Fmt 4700
Sfmt 4700
29055
for Regulatory Affairs, tel.: 202–622–
4855, Assistant Director for Sanctions
Compliance & Evaluation, tel.: 202–622–
2490; or the Department of the
Treasury’s Office of the Chief Counsel
(Foreign Assets Control), Office of the
General Counsel, tel.: 202–622–2410.
SUPPLEMENTARY INFORMATION:
Background
The Regulations set forth standard
reporting and recordkeeping
requirements and license application
and other procedures relevant to the
economic sanctions programs
administered by OFAC. OFAC is
updating six sections of the Regulations.
Reports on Blocked and Unblocked
Property
OFAC is revising § 501.603 of the
Regulations, which covers reports on
blocked property, to provide greater
detail regarding the information
required to be provided to OFAC in
connection with blocking reports and to
expand this section to cover reports on
the release of property from blocked
status (i.e., unblocked property), as well
as to make certain technical and
conforming changes related thereto. As
a general matter, in the past, when a
submitter has not provided sufficient
information to identify blocked or
unblocked property and to determine
the authority or authorities under which
it was blocked or unblocked, OFAC has
requested follow up information from
the submitter, sometimes requiring
multiple requests. OFAC is expanding
the information listed in § 501.603 that
is required to be submitted in reports on
blocked property in an effort to clarify
what information is needed to reduce
the need for follow up requests from
OFAC and in order to lessen the overall
reporting burden for submitters.
Initial blocking reports. The expanded
instructions for initial blocking reports
require submitters to include the
following information: (1) The name
and address of the person holding the
blocked property and a contact person
from whom additional information may
be obtained; (2) a description of any
transaction associated with the
blocking, including certain identifying
information; (3) the associated sanctions
target(s) whose property is blocked or a
reference to the relevant written
communication from OFAC if there is
no associated target or that target is
unknown; (4) a description of the
property that is the subject of the
blocking and its location; (5) the date
the property was blocked; (6) the actual,
or if unknown, estimated value of the
property in U.S. Dollars; (7) the legal
authority or authorities under which the
E:\FR\FM\21JNR1.SGM
21JNR1
Agencies
[Federal Register Volume 84, Number 120 (Friday, June 21, 2019)]
[Rules and Regulations]
[Pages 29054-29055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13223]
[[Page 29054]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 117 and 507
[Docket No. FDA-2018-D-0671]
Determining the Number of Employees for Purposes of the ``Small
Business'' Definition (Current Good Manufacturing Practices and
Preventive Controls Regulations for Human and Animal Food): Guidance
for Industry; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a final guidance for industry describing the
Agency's current thinking on how to determine the number of employees
for purposes of the ``small business'' definition in the current good
manufacturing practice (CGMP), hazard analysis, and risk-based
preventive controls for human and animal food rules. The guidance will
help industry subject to these rules determine the number of employees
for purposes of the ``small business'' definition.
DATES: The announcement of the guidance is published in the Federal
Register on June 21, 2019.
ADDRESSES: You may submit either electronic or written comments on
Agency guidances at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2018-D-0671 for ``Determining the Number of Employees for Purposes
of the `Small Business' Definition in Parts 117 and 507 (CGMP and
Preventive Controls Regulations for Human and Animal Food): Guidance
for Industry.'' Received comments will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single copies of the guidance to the
Center for Food Safety and Applied Nutrition, Food and Drug
Administration, 5001 Campus Dr., College Park, MD 20740. Send two self-
addressed adhesive labels to assist that office in processing your
request. See the SUPPLEMENTARY INFORMATION section for electronic
access to the guidance.
FOR FURTHER INFORMATION CONTACT:
For questions relating to CGMP, Hazard Analysis, and Risk-Based
Preventive Controls for Human Food: Jenny Scott, Center for Food Safety
and Applied Nutrition (HFS-300), Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740, 240-402-2166.
For questions relating to CGMP, Hazard Analysis, and Risk-Based
Preventive Controls for Food for Animals: Jeanette Murphy, Center for
Veterinary Medicine (HFV-200), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-402-6246.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of a guidance for industry
entitled ``Determining the Number of Employees for Purposes of the
`Small Business' Definition in Parts 117 and 507 (CGMP and Preventive
Controls Regulations for Human and Animal Food): Guidance for
Industry.'' We are issuing the guidance consistent with our good
guidance practices regulation (21 CFR 10.115). The guidance represents
the current thinking of FDA on this topic. It does not establish any
rights for any person and is not binding on FDA or the public. You can
use an alternative approach if it satisfies the requirements of the
applicable statutes and regulations. This guidance is not subject to
Executive Order 12866.
This guidance concerns two regulations that we have established in
[[Page 29055]]
Title 21 of the Code of Federal Regulations (21 CFR) as part of our
implementation of the FDA Food Safety Modernization Act (FSMA) (Pub. L.
111-353). These two regulations are part 117 (21 CFR part 117)
(September 17, 2015, 80 FR 55907) and part 507 (21 CFR part 507)
(September 17, 2015, 80 FR 51670). Under parts 117 and 507, whether a
business is a ``small business'' has two main implications. First,
certain small businesses are exempt from the human food preventive
controls requirements and the animal food preventive controls
requirements if they are engaged only in specified low-risk activity/
food combinations. Second, small businesses have later compliance dates
for parts 117 and 507 than larger businesses. This guidance provides
additional information to assist businesses in determining their status
as a ``small business.''
In the Federal Register of March 20, 2018 (83 FR 12143), we made
available a draft guidance for industry entitled ``Determining the
Number of Employees for Purposes of the `Small Business' Definition in
Parts 117 and 507: Guidance for Industry'' and gave interested parties
an opportunity to submit comments by May 21, 2018, for us to consider
before beginning work on the final version of the guidance. We received
no substantive comments on the draft guidance and are issuing the
guidance with editorial changes to improve clarity and revision of one
example to improve usefulness. The guidance announced in this notice
finalizes the draft guidance dated March 2018.
II. Electronic Access
Persons with access to the internet may obtain the guidance at
either https://www.fda.gov/FoodGuidances or https://www.regulations.gov. Use the FDA website listed in the previous
sentence to find the most current version of the guidance.
Dated: June 17, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-13223 Filed 6-20-19; 8:45 am]
BILLING CODE 4164-01-P